Edgestream Partners’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.98M Buy
32,257
+24,606
+322% +$2.47M 0.1% 385
2025
Q4
$781K Sell
7,651
-30,949
-80% -$2.77M 0.02% 741
2025
Q3
$2.41M Sell
38,600
-11,919
-24% -$648K 0.07% 475
2025
Q2
$2.63M Buy
50,519
+30,094
+147% +$1.34M 0.07% 463
2025
Q1
$870K Buy
+20,425
New +$881K 0.03% 626
2024
Q3
Sell
-96,513
Closed -$2.79M 926
2024
Q2
$2.79M Buy
96,513
+49,574
+106% +$1.15M 0.13% 247
2024
Q1
$968K Buy
46,939
+37,085
+376% +$795K 0.05% 511
2023
Q4
$267K Buy
+9,854
New +$258K 0.02% 743

Other funds holding GH

Edgestream Partners's GH Position: Q1 2026 in Review

Edgestream Partners increased its Guardant Health (GH) stake by 322% in Q1 2026, buying an estimated $2.47M and bringing the position to 32,257 shares worth $2.98M. The position accounts for 0.1% of the portfolio, ranked #385.

Edgestream Partners first reported a position in GH in Q4 2023 and has held it in 8 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Edgestream Partners held 32,257 shares of Guardant Health worth $2.98M as of Q1 2026.
  • Edgestream Partners bought 24,606 Guardant Health shares in Q1 2026, an estimated $2.47M.
  • Guardant Health made up 0.1% of Edgestream Partners's portfolio in Q1 2026, its #385 holding.
  • Edgestream Partners first reported a position in Guardant Health in Q4 2023 and has held it in 8 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.